🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Activated clotting time (ACT) is currently recommended to monitor high conc...
Status
Withdrawn
Location
Service de chirurgie vasculaire (U50) Hôpital Louis Pradel - HCL
Start Date
2022-11
Trial ID
NCT05554055
Treatments Being Tested
The measurement of anti-Xa activity is classically used for the dose adjust...
Status
Completed
Location
CHU Bordeaux
Start Date
2020-01-16
Trial ID
NCT04700670
Treatments Being Tested
The aim of this study is to investigate and compare the mortality, the inci...
Status
Completed
Location
Jessa hospital
Start Date
2020-05-04
Trial ID
NCT04394000
Treatments Being Tested
This study aims to compare the accuracy of two different blood sampling met...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-01
Trial ID
NCT07365670
Treatments Being Tested
Fondaparinux is a synthetic antithrombotic agent with specific anti-factor ...
Status
Completed
Location
CHARRET Françoise
Start Date
2004-09
Trial ID
NCT01063543
Unfractionated heparin (UFH) and low molecular weight heparins (LMWH) provi...
Status
Recruiting
Location
Laboratoire d'Hématologie - Unité d'Hémostase - CHU de Strasbourg - France
Start Date
2024-12-03
Trial ID
NCT07302620
After bariatric surgery , thromboembolics complications are major cause of ...
Status
Completed
Location
Assistance Publique - Hôpitaux de Paris
Start Date
2010-02
Trial ID
NCT01064596
Treatments Being Tested
To assess the safety and descriptive efficacy of apixaban in pediatric subj...
Status
Completed
Location
Pediatric Cardiology Clinic
Start Date
2015-11-22
Trial ID
NCT02464969
Treatments Being Tested
Allograft vascular thrombosis is a devastating complication in kidney trans...
Status
Completed
Location
Hôpital Pellegrin
Start Date
2023-06-28
Trial ID
NCT05672550
Treatments Being Tested